Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon-alpha and autoimmune thyroid disease.

Mark F Prummel1, Peter Laurberg

  • 1Department of Endocrinology and Metabolism, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. m.f.prummel@amc.uva.nl

Thyroid : Official Journal of the American Thyroid Association
|August 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antithyroid drug therapy of Graves' hyperthyroidism: realistic goals and focus on evidence.

Expert review of endocrinology & metabolism·2019
Same author

Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment - Data Using a Blind, Randomized, Clinical Study.

European thyroid journal·2017
Same author

The role of genes, intelligence, personality, and social engagement in cognitive performance in Klinefelter syndrome.

Brain and behavior·2017
Same author

MANAGEMENT OF ENDOCRINE DISEASE: Subclinical thyrotoxicosis: prevalence, causes and choice of therapy.

European journal of endocrinology·2017
Same author

Reliability of thyroglobulin in serum compared with urinary iodine when assessing individual and population iodine nutrition status.

The British journal of nutrition·2017
Same author

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.

Thyroid : official journal of the American Thyroid Association·2017
Same journal

Stimulating Thyrotropin Receptor Antibodies Enhance the Expression of Both Thyrotropin Receptors and Insulin-Like Growth Factor 1 Receptors in Fibroblasts.

Thyroid : official journal of the American Thyroid Association·2026
Same journal

Mild Thyroid Eye Disease-The Most Common yet the Least Studied Presentation of Thyroid Eye Disease.

Thyroid : official journal of the American Thyroid Association·2026
Same journal

In Memoriam: Lawrence Crane Wood (1935-2026).

Thyroid : official journal of the American Thyroid Association·2026
Same journal

Trends in Management and Outcomes of Pediatric Hyperthyroidism Over Two Decades.

Thyroid : official journal of the American Thyroid Association·2026
Same journal

Targeted Therapy-Induced Erythrocytosis in Thyroid Cancers: An Underrecognized Safety Signal from a Retrospective Study.

Thyroid : official journal of the American Thyroid Association·2026
Same journal

<i>Retraction Notice:</i> High Iodine Concentration Attenuates <i>RET/PTC3</i> Oncogene Activation in Thyroid Follicular Cells.

Thyroid : official journal of the American Thyroid Association·2026
See all related articles

Interferon-alpha (IFN alpha) therapy for Hepatitis C Virus (HCV) can trigger autoimmune thyroid disease (AITD). Women and those with pre-existing thyroid peroxidase antibodies face a higher risk of developing AITD during treatment.

Area of Science:

  • Endocrinology
  • Immunology
  • Hepatology

Background:

  • Interferon-alpha (IFN alpha) is a primary treatment for Hepatitis C Virus (HCV) infection.
  • IFN alpha, while generally safe, is associated with inducing autoantibodies and autoimmune diseases.
  • Autoimmune thyroid disease (AITD) is a notable concern in patients undergoing IFN alpha therapy.

Purpose of the Study:

  • To review the induction of AITD in HCV-infected patients treated with IFN alpha.
  • To identify risk factors associated with IFN alpha-induced AITD.
  • To explore the link between endogenous IFN alpha levels and naturally occurring AITD.

Main Methods:

  • Review of literature on IFN alpha therapy and AITD in HCV patients.
  • Analysis of relative risks for AITD development based on patient demographics and pre-existing conditions.

Related Experiment Videos

  • Examination of the types and prevalence of IFN alpha-associated AITD.

    • Main Results:

    • Female patients have a 4.4 times higher risk of developing AITD during IFN alpha treatment.
    • Individuals with pre-therapy thyroid peroxidase antibodies show a 3.9 times higher risk for AITD.
    • Common IFN alpha-associated AITD include hypothyroidism, Graves' hyperthyroidism, and destructive thyroiditis, with hypothyroidism being most frequent.

    Conclusions:

    • IFN alpha is an environmental factor that can trigger AITD in genetically predisposed individuals.
    • The findings suggest a potential association between high endogenous IFN alpha levels and naturally occurring AITD.
    • Understanding these risks is crucial for managing HCV patients on IFN alpha therapy.